Position in AZN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,040,802
-$186,805 QoQ
Shares Held
21,310
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#420
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Madison Asset Management, LLC holds $138,988,503 across 8 Drug Manufacturers - General names. AZN ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
55,520 | $66,592,359 | |
| 2 | JNJ |
Johnson & Johnson
|
136,792 | $34,741,064 | |
| 3 | ABBV |
AbbVie Inc.
|
79,651 | $20,043,377 | |
| 4 | PFE |
Pfizer Inc
|
242,132 | $5,830,538 | |
| 5 | AMGN |
Amgen Inc
|
11,539 | $4,178,502 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
21,310 | $4,040,802 | |
| 7 | MRK |
Merck & Co., Inc.
|
23,786 | $3,056,501 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,000 | $505,360 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,040,802 | 21,310 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,227,607 | 21,436 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||